Kamei J, Ogawa M, Kasuya Y
Department of Pharmacology, School of Pharmacy, Hoshi University, Tokyo, Japan.
Pharmacol Biochem Behav. 1990 Feb;35(2):473-5. doi: 10.1016/0091-3057(90)90188-n.
To investigate the possible mechanisms involved in the alterations in sensitivity to pain in diabetic rats, we examined the influence of diabetes induced by streptozotocin (STZ) on the functions of the neuronal systems that contain substance P (SP) within the spinal cord. The threshold for pain perception as determined by a tail-pinch test was significantly reduced in diabetic rats. The levels of SP in the spinal cord from diabetic rats (116.9 +/- 16.3 pmol/g tissue) were significantly lower than those from the control rats (190.2 +/- 14.1 pmol/g tissue). Diabetic rats were found to have a significant increase in the number of binding sites for SP in dorsal spinal cord. The concentrations of binding sites in diabetic rats and in control rats were 102.1 +/- 17.3 fmol/mg protein and 52.6 +/- 6.6 fmol/mg protein, respectively. These data indicate that STZ-induced diabetic rats exhibit supersensitivity to SP in the spinal cord. This may be correlated, in part, with the reduction in the threshold for perception of pain in diabetic animals.
为了研究糖尿病大鼠疼痛敏感性改变可能涉及的机制,我们检测了链脲佐菌素(STZ)诱导的糖尿病对脊髓内含有P物质(SP)的神经元系统功能的影响。通过夹尾试验确定的糖尿病大鼠的痛觉阈值显著降低。糖尿病大鼠脊髓中SP的水平(116.9±16.3 pmol/g组织)显著低于对照大鼠(190.2±14.1 pmol/g组织)。发现糖尿病大鼠脊髓背角中SP的结合位点数量显著增加。糖尿病大鼠和对照大鼠的结合位点浓度分别为102.1±17.3 fmol/mg蛋白质和52.6±6.6 fmol/mg蛋白质。这些数据表明,STZ诱导的糖尿病大鼠脊髓对SP表现出超敏反应。这可能部分与糖尿病动物痛觉阈值降低有关。